相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: An updated systematic review and meta-analysis
Changcheng Shi et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
J. Turnidge et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
Lindsay M. Avery et al.
CLINICAL INFECTIOUS DISEASES (2019)
Concerns About the Association Between Poor Clinical Outcomes and the Minimum Inhibitory Concentrations Determined by Etest
Aristine Cheng et al.
CLINICAL INFECTIOUS DISEASES (2019)
Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia
Lindsay M. Avery et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Bacterial resistance in the intensive care unit of developing countries: Report from a tertiary hospital in Kazakhstan
Dmitriy Viderman et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
Efficacy of Daptomycin Monotherapy and In Combination with β-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect
Razieh Kebriaei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests
Shelley A. Campeau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model
James M. Kidd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Effect of Statin Coadministration on the Risk of Daptomycin-Associated Myopathy
Ryan K. Dare et al.
CLINICAL INFECTIOUS DISEASES (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
Yu-Chung Chuang et al.
SCIENTIFIC REPORTS (2018)
Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans
Johannes J. M. van Delden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia
Yu-Chung Chuang et al.
CLINICAL INFECTIOUS DISEASES (2017)
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
Bhavarth S. Shukla et al.
CLINICAL INFECTIOUS DISEASES (2016)
Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose
Y-C. Chuang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia
Pamela A. Moise et al.
CLINICAL THERAPEUTICS (2015)
Interethnic Differences in Pharmacokinetics of Antibacterials
Danny Tsai et al.
CLINICAL PHARMACOKINETICS (2015)
Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
George Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model
Ashley Hall Snyder et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
A Current Perspective on Daptomycin for the Clinical Microbiologist
Romney M. Humphries et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
George Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Correlation between Mutations in liaFSR of Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
Jose M. Munita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia
Yu-Chung Chuang et al.
CLINICAL INFECTIOUS DISEASES (2011)
Management of multidrug-resistant enterococcal infections
C. A. Arias et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Therapeutic options for infections due to vancomycin-resistant enterococci
Jiun-Ling Wang et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
In vivo pharmacodynamic activity of daptomycin
N Safdar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infection
J Alder et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media
PC Fuchs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
MJ Rybak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Drug therapy: Vancomycin-resistant enterococcal infections.
BE Murray
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
